Results 241 to 250 of about 485,740 (261)

FDA Regulation of Prescription Drugs

New England Journal of Medicine, 2017
Hylton V Joffe
exaly  

Regulatory Review of New Therapeutic Agents — FDA versus EMA, 2011–2015

New England Journal of Medicine, 2017
Audrey Zhang, Joseph S Ross, Ross Joseph S   +2 more
exaly  

An FDA Viewpoint on Unique Considerations for Medical-Device Clinical Trials

New England Journal of Medicine, 2017
Jeffrey Shuren
exaly  

FDA Initiative for Drug Facts Label for Over-the-Counter Naloxone

New England Journal of Medicine, 2020
Janet Woodcock
exaly  

The FDA and Genetic Testing

New England Journal of Medicine, 2015
Jeffrey Shuren
exaly  

Breakthrough-Therapy Designation — An FDA Perspective

New England Journal of Medicine, 2018
Amy Mckee
exaly  

DISMANTLING THE FDA

American Journal of Therapeutics, 1995
openaire   +2 more sources

Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date

Pharmaceutical Research, 2016
Simon Robert Corrie, Kristofer Thurecht, Daniel Paul Bobo   +2 more
exaly  

Califf for the FDA

New England Journal of Medicine, 2016
Jeffrey Dražen, Dražen Jeffrey M
exaly  

How The FDA Evaluates Drugs Related To Cancer

Ca-A Cancer Journal for Clinicians, 1967
exaly